THL Partners closes Fund X at $6.35bn

About THL Partners

  • Founded: 1974

  • Headquarters: Boston, Massachusetts

  • AUM: Approximately $35bn as of 2024

  • Strategy: Middle-market buyout, North America, with sector focus on healthcare, financial services, technology, and business services

  • Track record: Managed nine prior flagship funds; Fund IX closed at $5.6bn in 2021, Fund VIII raised $4.35bn in 2018

  • Leadership: Scott Sperling (co-chairman), Anthony DiNovi (co-chairman), and Scott Schoen (president)

THL Partners closed its tenth flagship fund at $6.35bn in final close, exceeding the $6.25bn target and marking a 13% increase over Fund IX's $5.6bn raised in 2021. The firm has now raised approximately $10bn across two consecutive vintages over three years, maintaining steady cadence despite a compressed fundraising environment for middle-market managers.

The raise positions THL as a persistent winner in the $5bn+ mid-market buyout tier, but the modest step-up from Fund IX — roughly in line with inflation — reflects what appears to be disciplined sizing rather than aggressive expansion. Two comparable raises from peers in the same bracket tell different stories: Vista Equity Partners closed its eighth flagship at $10bn in mid-2023, a 33% jump from Fund VII, while Thoma Bravo's Fund XVI closed at $12.4bn in early 2024 after a protracted raise that took 18 months. THL's sub-12-month close at target-plus suggests stable LP appetite for established managers who haven't overreached on fund size relative to prior deployment pace.

The question worth watching is deployment velocity against a tightening exit environment. THL's Fund IX is roughly three years into deployment, and the firm has historically targeted 3–4 year investment periods. If Fund X follows the same cadence with a 15% larger capital base, deal sizes will need to scale modestly or deal count will need to tick up — both harder to execute in a market where middle-market multiples remain elevated and financing costs haven't fully reset. The firm's sector concentration in healthcare and financial services provides some insulation, but the next 18 months of deployment will clarify whether the fund-size discipline was matched by entry-price discipline.

Source: Private Equity Wire